Proteome Sciences (PRM) Competitors

GBX 1.40 -0.08 (-5.41%)

As of 05/8/2026 12:08 PM Eastern

PRM vs. VGAS, ALB, ADES, LOOP, and PPG

Should you be buying Proteome Sciences stock or one of its competitors? The main competitors of Proteome Sciences include Volga Gas (VGAS), Albert Technologies (ALB), ADES International (ADES), LoopUp Group (LOOP), and Plutus PowerGen (PPG). These companies are all part of the "chemicals" industry.

How does Proteome Sciences compare to Volga Gas?

Volga Gas (LON:VGAS) and Proteome Sciences (LON:PRM) are both small-cap chemicals companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

In the previous week, Volga Gas' average media sentiment score of 0.00 equaled Proteome Sciences'average media sentiment score.

Company	Overall Sentiment
Volga Gas	Neutral
Proteome Sciences	Neutral

Volga Gas has a net margin of 0.00% compared to Proteome Sciences' net margin of -81.50%. Proteome Sciences' return on equity of 33.80% beat Volga Gas' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Volga Gas	N/A	N/A	N/A
Proteome Sciences	-81.50%	33.80%	-19.25%

Volga Gas has higher revenue and earnings than Proteome Sciences. Proteome Sciences is trading at a lower price-to-earnings ratio than Volga Gas, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Volga Gas	£18.73M	0.00	N/A	-£19.20	N/A
Proteome Sciences	£3.76M	1.31	-£4.08M	-£1.04	N/A

0.0% of Proteome Sciences shares are owned by institutional investors. 36.7% of Proteome Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Volga Gas and Proteome Sciences tied by winning 4 of the 8 factors compared between the two stocks.

How does Proteome Sciences compare to Albert Technologies?

Albert Technologies (LON:ALB) and Proteome Sciences (LON:PRM) are both small-cap chemicals companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

0.0% of Proteome Sciences shares are owned by institutional investors. 36.7% of Proteome Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Albert Technologies' average media sentiment score of 0.00 equaled Proteome Sciences'average media sentiment score.

Company	Overall Sentiment
Albert Technologies	Neutral
Proteome Sciences	Neutral

Albert Technologies has a net margin of 0.00% compared to Proteome Sciences' net margin of -81.50%. Proteome Sciences' return on equity of 33.80% beat Albert Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Albert Technologies	N/A	N/A	N/A
Proteome Sciences	-81.50%	33.80%	-19.25%

Albert Technologies has higher revenue and earnings than Proteome Sciences. Proteome Sciences is trading at a lower price-to-earnings ratio than Albert Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Albert Technologies	£4.61M	0.00	N/A	-£15.10	N/A
Proteome Sciences	£3.76M	1.31	-£4.08M	-£1.04	N/A

Summary

Albert Technologies and Proteome Sciences tied by winning 4 of the 8 factors compared between the two stocks.

How does Proteome Sciences compare to ADES International?

ADES International (LON:ADES) and Proteome Sciences (LON:PRM) are both small-cap chemicals companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, risk, profitability, valuation and earnings.

In the previous week, ADES International's average media sentiment score of 0.00 equaled Proteome Sciences'average media sentiment score.

Company	Overall Sentiment
ADES International	Neutral
Proteome Sciences	Neutral

ADES International has higher revenue and earnings than Proteome Sciences. Proteome Sciences is trading at a lower price-to-earnings ratio than ADES International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ADES International	£452.11M	0.00	N/A	£0.46	N/A
Proteome Sciences	£3.76M	1.31	-£4.08M	-£1.04	N/A

ADES International has a net margin of 0.00% compared to Proteome Sciences' net margin of -81.50%. Proteome Sciences' return on equity of 33.80% beat ADES International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ADES International	N/A	N/A	N/A
Proteome Sciences	-81.50%	33.80%	-19.25%

Summary

ADES International beats Proteome Sciences on 5 of the 8 factors compared between the two stocks.

How does Proteome Sciences compare to LoopUp Group?

LoopUp Group (LON:LOOP) and Proteome Sciences (LON:PRM) are both small-cap chemicals companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends, media sentiment and profitability.

LoopUp Group has a beta of -0.04, meaning that its share price is 104% less volatile than the S&P 500. Comparatively, Proteome Sciences has a beta of 0.07, meaning that its share price is 93% less volatile than the S&P 500.

24.2% of LoopUp Group shares are held by institutional investors. Comparatively, 0.0% of Proteome Sciences shares are held by institutional investors. 64.7% of LoopUp Group shares are held by company insiders. Comparatively, 36.7% of Proteome Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Proteome Sciences has lower revenue, but higher earnings than LoopUp Group. Proteome Sciences is trading at a lower price-to-earnings ratio than LoopUp Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LoopUp Group	£22.07M	0.00	-£16.28M	-£0.12	N/A
Proteome Sciences	£3.76M	1.31	-£4.08M	-£1.04	N/A

In the previous week, LoopUp Group's average media sentiment score of 0.00 equaled Proteome Sciences'average media sentiment score.

Company	Overall Sentiment
LoopUp Group	Neutral
Proteome Sciences	Neutral

LoopUp Group has a net margin of -73.76% compared to Proteome Sciences' net margin of -81.50%. Proteome Sciences' return on equity of 33.80% beat LoopUp Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LoopUp Group	-73.76%	-41.98%	-6.17%
Proteome Sciences	-81.50%	33.80%	-19.25%

Summary

LoopUp Group beats Proteome Sciences on 6 of the 10 factors compared between the two stocks.

How does Proteome Sciences compare to Plutus PowerGen?

Plutus PowerGen (LON:PPG) and Proteome Sciences (LON:PRM) are both small-cap chemicals companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

In the previous week, Plutus PowerGen's average media sentiment score of 0.00 equaled Proteome Sciences'average media sentiment score.

Company	Overall Sentiment
Plutus PowerGen	Neutral
Proteome Sciences	Neutral

0.0% of Proteome Sciences shares are held by institutional investors. 36.7% of Proteome Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Plutus PowerGen has higher earnings, but lower revenue than Proteome Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Plutus PowerGen	£1.17M	0.00	N/A	N/A	N/A
Proteome Sciences	£3.76M	1.31	-£4.08M	-£1.04	N/A

Plutus PowerGen has a net margin of 0.00% compared to Proteome Sciences' net margin of -81.50%. Proteome Sciences' return on equity of 33.80% beat Plutus PowerGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Plutus PowerGen	N/A	N/A	N/A
Proteome Sciences	-81.50%	33.80%	-19.25%

Summary

Proteome Sciences beats Plutus PowerGen on 4 of the 7 factors compared between the two stocks.

Get Proteome Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRM vs. The Competition

Export

Metric	Proteome Sciences	Diagnostics & Research Industry	Medical Sector	LON Exchange
Market Cap	£4.91M	£45.78M	£6.23B	£2.77B
Dividend Yield	6.17%	3.59%	2.78%	6.15%
P/E Ratio	-1.35	0.94	21.19	366.07
Price / Sales	1.31	616.21	535.98	88,620.40
Price / Cash	3.73	11.42	43.07	27.89
Price / Book	-0.78	3.63	9.97	7.72
Net Income	-£4.08M	£334.07B	£3.55B	£5.89B
7 Day Performance	-24.32%	-0.56%	3.51%	63.96%
1 Month Performance	-11.39%	2.31%	4.91%	3.12%
1 Year Performance	-53.33%	17.02%	41.94%	87.68%

Proteome Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRM Proteome Sciences	N/A	GBX 1.40 -5.4%	N/A	-53.3%	£4.91M	£3.76M	N/A	240	Gap Down
VGAS Volga Gas	N/A	N/A	N/A	N/A	£18.99M	£18.73M	N/A	2
ALB Albert Technologies	N/A	N/A	N/A	N/A	£7.98M	£4.61M	N/A	7,400	Gap Up High Trading Volume
ADES ADES International	N/A	N/A	N/A	N/A	£5.09M	£452.11M	26.62	140
LOOP LoopUp Group	N/A	N/A	N/A	N/A	£1.43M	£22.07M	N/A	90

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:PRM) was last updated on 5/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Proteome Sciences (PRM) Competitors

PRM vs. VGAS, ALB, ADES, LOOP, and PPG

How does Proteome Sciences compare to Volga Gas?

Summary

How does Proteome Sciences compare to Albert Technologies?

Summary

How does Proteome Sciences compare to ADES International?

Summary

How does Proteome Sciences compare to LoopUp Group?

Summary

How does Proteome Sciences compare to Plutus PowerGen?

Summary

Media Sentiment Over Time

PRM vs. The Competition

Proteome Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Proteome Sciences (PRM) Competitors

PRM vs. VGAS, ALB, ADES, LOOP, and PPG

How does Proteome Sciences compare to Volga Gas?

Does the media favor VGAS or PRM?

Is VGAS or PRM more profitable?

Which has preferable valuation and earnings, VGAS or PRM?

Do insiders & institutionals have more ownership in VGAS or PRM?

Summary

How does Proteome Sciences compare to Albert Technologies?

Do insiders and institutionals have more ownership in ALB or PRM?

Does the media prefer ALB or PRM?

Is ALB or PRM more profitable?

Which has better earnings and valuation, ALB or PRM?

Summary

How does Proteome Sciences compare to ADES International?

Do insiders & institutionals hold more shares of ADES or PRM?

Does the media refer more to ADES or PRM?

Which has higher earnings and valuation, ADES or PRM?

Is ADES or PRM more profitable?

Summary

How does Proteome Sciences compare to LoopUp Group?

Which has more volatility & risk, LOOP or PRM?

Do institutionals & insiders believe in LOOP or PRM?

Which has stronger valuation and earnings, LOOP or PRM?

Does the media favor LOOP or PRM?

Is LOOP or PRM more profitable?

Summary

How does Proteome Sciences compare to Plutus PowerGen?

Does the media refer more to PPG or PRM?

Do institutionals and insiders believe in PPG or PRM?

Which has better earnings & valuation, PPG or PRM?

Is PPG or PRM more profitable?

Summary

Media Sentiment Over Time

PRM vs. The Competition

Proteome Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools